Report cover image

Global Immune Health Product Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 194 Pages
SKU # APRC20360972

Description

Summary

According to APO Research, The global Immune Health Product market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Immune Health Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Immune Health Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Immune Health Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Immune Health Product is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Immune Health Product include China New Era Group, INFINITUS, Real Nutriceutical, PERFECT, By-health, H&H Group, USANA Health Sciences, Inc., Suntory and Nestlé SA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Immune Health Product, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Immune Health Product, also provides the revenue of main regions and countries. Of the upcoming market potential for Immune Health Product, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Immune Health Product revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Immune Health Product market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Immune Health Product revenue, projected growth trends, production technology, application and end-user industry.

Immune Health Product Segment by Company

China New Era Group
INFINITUS
Real Nutriceutical
PERFECT
By-health
H&H Group
USANA Health Sciences, Inc.
Suntory
Nestlé SA
Nature’s
Herbalife Nutrition
GNC
Glanbia Plc
Black Mores
Amway
Immune Health Product Segment by Type

Powder
Capsule/Pills
Liquid
Immune Health Product Segment by Application

Men
The Elderly
Children/Teenagers
Adults
Immune Health Product Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Health Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Health Product and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Health Product.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Immune Health Product in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Immune Health Product company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immune Health Product revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

194 Pages
1 Market Overview
1.1 Product Definition
1.2 Immune Health Product Market by Type
1.2.1 Global Immune Health Product Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Powder
1.2.3 Capsule/Pills
1.2.4 Liquid
1.3 Immune Health Product Market by Application
1.3.1 Global Immune Health Product Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Men
1.3.3 The Elderly
1.3.4 Children/Teenagers
1.3.5 Adults
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Immune Health Product Market Dynamics
2.1 Immune Health Product Industry Trends
2.2 Immune Health Product Industry Drivers
2.3 Immune Health Product Industry Opportunities and Challenges
2.4 Immune Health Product Industry Restraints
3 Global Growth Perspective
3.1 Global Immune Health Product Market Perspective (2020-2031)
3.2 Global Immune Health Product Growth Trends by Region
3.2.1 Global Immune Health Product Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Immune Health Product Market Size by Region (2020-2025)
3.2.3 Global Immune Health Product Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Immune Health Product Revenue by Players
4.1.1 Global Immune Health Product Revenue by Players (2020-2025)
4.1.2 Global Immune Health Product Revenue Market Share by Players (2020-2025)
4.1.3 Global Immune Health Product Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Immune Health Product Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Immune Health Product Key Players Headquarters & Area Served
4.4 Global Immune Health Product Players, Product Type & Application
4.5 Global Immune Health Product Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Immune Health Product Market CR5 and HHI
4.6.3 2024 Immune Health Product Tier 1, Tier 2, and Tier 3
5 Immune Health Product Market Size by Type
5.1 Global Immune Health Product Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Immune Health Product Revenue by Type (2020-2031)
5.3 Global Immune Health Product Revenue Market Share by Type (2020-2031)
6 Immune Health Product Market Size by Application
6.1 Global Immune Health Product Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Immune Health Product Revenue by Application (2020-2031)
6.3 Global Immune Health Product Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 China New Era Group
7.1.1 China New Era Group Comapny Information
7.1.2 China New Era Group Business Overview
7.1.3 China New Era Group Immune Health Product Revenue and Gross Margin (2020-2025)
7.1.4 China New Era Group Immune Health Product Product Portfolio
7.1.5 China New Era Group Recent Developments
7.2 INFINITUS
7.2.1 INFINITUS Comapny Information
7.2.2 INFINITUS Business Overview
7.2.3 INFINITUS Immune Health Product Revenue and Gross Margin (2020-2025)
7.2.4 INFINITUS Immune Health Product Product Portfolio
7.2.5 INFINITUS Recent Developments
7.3 Real Nutriceutical
7.3.1 Real Nutriceutical Comapny Information
7.3.2 Real Nutriceutical Business Overview
7.3.3 Real Nutriceutical Immune Health Product Revenue and Gross Margin (2020-2025)
7.3.4 Real Nutriceutical Immune Health Product Product Portfolio
7.3.5 Real Nutriceutical Recent Developments
7.4 PERFECT
7.4.1 PERFECT Comapny Information
7.4.2 PERFECT Business Overview
7.4.3 PERFECT Immune Health Product Revenue and Gross Margin (2020-2025)
7.4.4 PERFECT Immune Health Product Product Portfolio
7.4.5 PERFECT Recent Developments
7.5 By-health
7.5.1 By-health Comapny Information
7.5.2 By-health Business Overview
7.5.3 By-health Immune Health Product Revenue and Gross Margin (2020-2025)
7.5.4 By-health Immune Health Product Product Portfolio
7.5.5 By-health Recent Developments
7.6 H&H Group
7.6.1 H&H Group Comapny Information
7.6.2 H&H Group Business Overview
7.6.3 H&H Group Immune Health Product Revenue and Gross Margin (2020-2025)
7.6.4 H&H Group Immune Health Product Product Portfolio
7.6.5 H&H Group Recent Developments
7.7 USANA Health Sciences, Inc.
7.7.1 USANA Health Sciences, Inc. Comapny Information
7.7.2 USANA Health Sciences, Inc. Business Overview
7.7.3 USANA Health Sciences, Inc. Immune Health Product Revenue and Gross Margin (2020-2025)
7.7.4 USANA Health Sciences, Inc. Immune Health Product Product Portfolio
7.7.5 USANA Health Sciences, Inc. Recent Developments
7.8 Suntory
7.8.1 Suntory Comapny Information
7.8.2 Suntory Business Overview
7.8.3 Suntory Immune Health Product Revenue and Gross Margin (2020-2025)
7.8.4 Suntory Immune Health Product Product Portfolio
7.8.5 Suntory Recent Developments
7.9 Nestlé SA
7.9.1 Nestlé SA Comapny Information
7.9.2 Nestlé SA Business Overview
7.9.3 Nestlé SA Immune Health Product Revenue and Gross Margin (2020-2025)
7.9.4 Nestlé SA Immune Health Product Product Portfolio
7.9.5 Nestlé SA Recent Developments
7.10 Nature’s
7.10.1 Nature’s Comapny Information
7.10.2 Nature’s Business Overview
7.10.3 Nature’s Immune Health Product Revenue and Gross Margin (2020-2025)
7.10.4 Nature’s Immune Health Product Product Portfolio
7.10.5 Nature’s Recent Developments
7.11 Herbalife Nutrition
7.11.1 Herbalife Nutrition Comapny Information
7.11.2 Herbalife Nutrition Business Overview
7.11.3 Herbalife Nutrition Immune Health Product Revenue and Gross Margin (2020-2025)
7.11.4 Herbalife Nutrition Immune Health Product Product Portfolio
7.11.5 Herbalife Nutrition Recent Developments
7.12 GNC
7.12.1 GNC Comapny Information
7.12.2 GNC Business Overview
7.12.3 GNC Immune Health Product Revenue and Gross Margin (2020-2025)
7.12.4 GNC Immune Health Product Product Portfolio
7.12.5 GNC Recent Developments
7.13 Glanbia Plc
7.13.1 Glanbia Plc Comapny Information
7.13.2 Glanbia Plc Business Overview
7.13.3 Glanbia Plc Immune Health Product Revenue and Gross Margin (2020-2025)
7.13.4 Glanbia Plc Immune Health Product Product Portfolio
7.13.5 Glanbia Plc Recent Developments
7.14 Black Mores
7.14.1 Black Mores Comapny Information
7.14.2 Black Mores Business Overview
7.14.3 Black Mores Immune Health Product Revenue and Gross Margin (2020-2025)
7.14.4 Black Mores Immune Health Product Product Portfolio
7.14.5 Black Mores Recent Developments
7.15 Amway
7.15.1 Amway Comapny Information
7.15.2 Amway Business Overview
7.15.3 Amway Immune Health Product Revenue and Gross Margin (2020-2025)
7.15.4 Amway Immune Health Product Product Portfolio
7.15.5 Amway Recent Developments
8 North America
8.1 North America Immune Health Product Revenue (2020-2031)
8.2 North America Immune Health Product Revenue by Type (2020-2031)
8.2.1 North America Immune Health Product Revenue by Type (2020-2025)
8.2.2 North America Immune Health Product Revenue by Type (2026-2031)
8.3 North America Immune Health Product Revenue Share by Type (2020-2031)
8.4 North America Immune Health Product Revenue by Application (2020-2031)
8.4.1 North America Immune Health Product Revenue by Application (2020-2025)
8.4.2 North America Immune Health Product Revenue by Application (2026-2031)
8.5 North America Immune Health Product Revenue Share by Application (2020-2031)
8.6 North America Immune Health Product Revenue by Country
8.6.1 North America Immune Health Product Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Immune Health Product Revenue by Country (2020-2025)
8.6.3 North America Immune Health Product Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Immune Health Product Revenue (2020-2031)
9.2 Europe Immune Health Product Revenue by Type (2020-2031)
9.2.1 Europe Immune Health Product Revenue by Type (2020-2025)
9.2.2 Europe Immune Health Product Revenue by Type (2026-2031)
9.3 Europe Immune Health Product Revenue Share by Type (2020-2031)
9.4 Europe Immune Health Product Revenue by Application (2020-2031)
9.4.1 Europe Immune Health Product Revenue by Application (2020-2025)
9.4.2 Europe Immune Health Product Revenue by Application (2026-2031)
9.5 Europe Immune Health Product Revenue Share by Application (2020-2031)
9.6 Europe Immune Health Product Revenue by Country
9.6.1 Europe Immune Health Product Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Immune Health Product Revenue by Country (2020-2025)
9.6.3 Europe Immune Health Product Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
9.6.9 Nordic Countries
10 China
10.1 China Immune Health Product Revenue (2020-2031)
10.2 China Immune Health Product Revenue by Type (2020-2031)
10.2.1 China Immune Health Product Revenue by Type (2020-2025)
10.2.2 China Immune Health Product Revenue by Type (2026-2031)
10.3 China Immune Health Product Revenue Share by Type (2020-2031)
10.4 China Immune Health Product Revenue by Application (2020-2031)
10.4.1 China Immune Health Product Revenue by Application (2020-2025)
10.4.2 China Immune Health Product Revenue by Application (2026-2031)
10.5 China Immune Health Product Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Immune Health Product Revenue (2020-2031)
11.2 Asia Immune Health Product Revenue by Type (2020-2031)
11.2.1 Asia Immune Health Product Revenue by Type (2020-2025)
11.2.2 Asia Immune Health Product Revenue by Type (2026-2031)
11.3 Asia Immune Health Product Revenue Share by Type (2020-2031)
11.4 Asia Immune Health Product Revenue by Application (2020-2031)
11.4.1 Asia Immune Health Product Revenue by Application (2020-2025)
11.4.2 Asia Immune Health Product Revenue by Application (2026-2031)
11.5 Asia Immune Health Product Revenue Share by Application (2020-2031)
11.6 Asia Immune Health Product Revenue by Country
11.6.1 Asia Immune Health Product Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Immune Health Product Revenue by Country (2020-2025)
11.6.3 Asia Immune Health Product Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Immune Health Product Revenue (2020-2031)
12.2 SAMEA Immune Health Product Revenue by Type (2020-2031)
12.2.1 SAMEA Immune Health Product Revenue by Type (2020-2025)
12.2.2 SAMEA Immune Health Product Revenue by Type (2026-2031)
12.3 SAMEA Immune Health Product Revenue Share by Type (2020-2031)
12.4 SAMEA Immune Health Product Revenue by Application (2020-2031)
12.4.1 SAMEA Immune Health Product Revenue by Application (2020-2025)
12.4.2 SAMEA Immune Health Product Revenue by Application (2026-2031)
12.5 SAMEA Immune Health Product Revenue Share by Application (2020-2031)
12.6 SAMEA Immune Health Product Revenue by Country
12.6.1 SAMEA Immune Health Product Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Immune Health Product Revenue by Country (2020-2025)
12.6.3 SAMEA Immune Health Product Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.